Skip to main content
. 2019 Mar 28;11(4):726. doi: 10.3390/nu11040726

Table 4.

Results from the stratified analysis.

(A) High-normal BP Placebo Test
Week n Mean (SD) n Mean (SD) Δ BP p
SBP 0 19 135.0 (3.0) 19 135.1 (3.7) 0.1
(−2.1 to 2.3)
0.9426
12 19 134.7 (10.5) 17 128.0 (8.2) −6.8
(−13.2 to −0.3)
0.0397
DBP 0 19 84.3 (4.2) 19 86.0 (4.0) 1.7
(−1.0 to 4.4)
0.2205
12 19 83.6 (5.3) 17 82.0 (7.6) −1.6
(−6.0 to 2.8)
0.4631
(B) Grade 1 HT Placebo Test
Week n Mean (SD) n Mean (SD) ΔBP p
SBP 0 24 144.0 (7.1) 24 144.5 (7.8) 0.5
(−3.9 to 4.8)
0.8247
12 23 139.1 (6.9) 24 136.3 (11.1) −2.8
(−8.3 to 2.6)
0.2995
DBP 0 24 93.4 (4.2) 24 93.7 (4.2) 0.2
(−2.2 to 2.7)
0.8495
12 23 89.8 (4.7) 24 90.5 (6.3) 0.6
(−2.6 to 3.9)
0.6989

Each value is expressed as the mean (SD). High-normal BP: high-normal blood pressure; Grade 1 HT: grade 1 hypertension. ΔBP indicates the difference in the averages of the test group and the placebo group (95% confidence interval).